Brand Name
|
Description |
---|---|
Buvidal® (buprenorphine) |
Buvidal® is indicated for the treatment of opioid dependence within a framework of medical, social and psychological treatment. Treatment is intended for use in adults and adolescents aged 16 years or over. |
Latuda® (lurasidone hydrochloride) |
Latuda® is indicated for the treatment of patients with schizophrenia, for adults aged 18 years and over. Latuda is indicated as monotherapy or as adjunctive therapy with lithium or valproate for acute treatment of depressive episodes associated with bipolar disorder type I in adults. In the treatment of depressive episodes associated with bipolar disorder type I, therapy should be initiated and monitored by a physician with clinical experience in the diagnosis and treatment of affective disorders. |
Brand Name
|
Description |
---|---|
Briviact® (brivaracetam) |
Briviact® is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. |
Neupro® (rotigotine transdermal patch) |
Neupro® is indicated for the treatment of the signs and symptoms of early-stage idiopathic Parkinson’s disease as monotherapy (without levodopa) or in combination with levodopa |
Vimpat® (lacosamide) |
Vimpat® is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy and in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy. |
Diseases
|
Description |
---|---|
Dravet syndrome |
Dravet syndrome is the most severe of a group of conditions known as SCN1A-related seizure disorders. Symptoms include seizures which first occur in infancy that are often triggered by high temperatures known as febrile seizures. In childhood, many types of seizures may occur and they may increase in frequency. Seizures may be difficult to treat. Other symptoms include loss of motor skills, intellectual disability, speech impairment, and difficulty with movement. For more information on available treatment options, please contact us on [email protected] |
Lennox-Gastaut syndrome |
Lennox-Gastaut syndrome is a form of severe epilepsy that begins in childhood. It is characterized by multiple types of seizures and intellectual disability. This condition can be caused by brain malformations, perinatal asphyxia (lack of oxygen), severe head injury, central nervous system infection and inherited degenerative or metabolic conditions. In about one-third of cases, no cause can be found. For more information on available treatment options, please contact us on [email protected] |
Tuberous sclerosis complex |
Tuberous sclerosis complex (TSC) is characterized by the growth of benign tumors throughout the body, including in the heart, brain, and kidneys. Certain symptoms develop before to birth, such as heart tumors (rhabdomyoma). Other symptoms become more obvious in childhood, such as developmental delay and skin changes. Lung and kidney tumors are more likely to develop in adulthood. For more information on available treatment options, please contact us on [email protected] |